Skip to Content

Grepafloxacin Pregnancy and Breastfeeding Warnings

Grepafloxacin is also known as: Raxar

Grepafloxacin Pregnancy Warnings

Grepafloxacin has been assigned to pregnancy category C. Animal studies have revealed evidence of maternal toxicity, decreases in fetal and placental weight, and in the number of ossified saccrococcygeal vertebrae. Grepafloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

See references

Grepafloxacin Breastfeeding Warnings

Grepafloxacin is excreted into human milk. Because of the potential for serious adverse effects in nursing infants, a decision should be made to discontinue nursing or discontinue administration of the drug, taking into account the importance of the drug to the mother.

Grepafloxacin was detectable in the breast milk of one patient studied on her ninth day of treatment at 4 to 5 hours after oral administration of 400 mg. Studies using oral radioactive grepafloxacin in lactating rats reported that the concentration of radioactivity observed in the milk was 16 times that observed in the blood.

See references

References for pregnancy information

  1. "Product Information. Raxar (grepafloxacin)." Glaxo Wellcome, Research Triangle Park, NC.

References for breastfeeding information

  1. "Product Information. Raxar (grepafloxacin)." Glaxo Wellcome, Research Triangle Park, NC.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.